Network origin in A. Keith Willard first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.
24
| Subsidiary | Pharmaceuticals: Major | 24 |
ICI Canada, Inc.
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to A. Keith Willard via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Founder Director/Board Member President | |
| CELGENE | Biotechnology | Treasurer Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Director/Board Member | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Founder Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| ECHO GLOBAL LOGISTICS, INC. | Trucking | Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Lafayette College | College/University | Undergraduate Degree | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chairman | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Founder | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| NEA 13 GP Ltd. | Director/Board Member | ||
| J.E.M. CAPITAL INC | Financial Conglomerates | Director/Board Member | |
| Bethesda Research Laboratories, Inc. | Chief Executive Officer | ||
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
| Dickinson College | College/University | Undergraduate Degree | |
| University of Birmingham | College/University | Doctorate Degree | |
The International Society for Antiviral Research
 The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Cardiff | College/University | Corporate Officer/Principal | |
| Welsh School of Pharmacy | College/University | Corporate Officer/Principal | |
Life Sciences Hub Wales Ltd.
 Life Sciences Hub Wales Ltd. Information Technology ServicesTechnology Services Life Sciences Hub Wales Ltd. is an innovation project management support company based in Cardiff Bay, UK. The British company's experienced and skilled team helps progress work towards transforming the health and economic wellbeing of the nation. The private company provides support in producing business cases that drive innovation projects towards clinical adoption. Life Sciences Hub Wales is an arm’s length body of Welsh Government that catalyses innovation and collaboration between industry, health, social care, and academia, making a positive difference to people, families, and businesses across the nation. The CEO of the company is Cari-Anne Quinn. | Information Technology Services | Chairman | |
| Life Sciences Research Network Wales | Director/Board Member | ||
| NUCANA PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
| New Mexico State University | College/University | Doctorate Degree |
Statistics
International
| United States | 41 |
| United Kingdom | 7 |
| Bermuda | 2 |
| Hong Kong | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Retail Trade | 2 |
| Transportation | 2 |
Operational
| Director/Board Member | 117 |
| Corporate Officer/Principal | 53 |
| Chairman | 43 |
| Independent Dir/Board Member | 27 |
| Founder | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Louis Sullivan | 31 |
| Gabriele Cerrone | 22 |
| Russell Medford | 21 |
| Christopher McGuigan | 17 |
| Joseph Patti | 14 |
| Mike A. Henos | 11 |
| Katherine Reynolds Kelly | 10 |
| Kabir Kumar Nath | 9 |
| Seth V. Hetherington | 9 |
| Jeff T. Hutchins | 7 |
| Robert A. Hamm | 7 |
| John H. Vernachio | 7 |
| Uday Patel | 7 |
| Jeffrey Galik | 7 |
- Stock Market
- Insiders
- A. Keith Willard
- Company connections
